Fundz

Who to call at Transgene, and when

Fundz watches for the moments Transgene starts buying, and tells you who to reach.

  • An alert the day Transgene raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Transgene, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Transgene and ProBioGen Enter License Agreement for Individualized Cancer Vaccine Development

Nov 05, 2024

Contract Type

partnership

Bas-RhinBiotechnologyHealth CareTherapeutics

Description

Transgene and ProBioGen have entered into a partnership to advance individualized cancer vaccine development. The collaboration aims to combine ProBioGen's specific production technology with Transgene's individualized cancer vaccine program and its myvac® platform.

Company Information

Company

Transgene

Location

Bas-Rhin, Grand Est, France

About

Transgene is a biotechnology company focused on designing and developing targeted immunotherapies for the treatment of cancer. The Company’s clinical-stage programs consist of a portfolio of therapeutic vaccines and oncolytic viruses with the goal of indirectly or directly killing cancer cells.

Related People

James
Likely contact at this company
••••••••@••••••••

See James's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Transgene's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

Transgene signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.